U.S. REITS Stock News

Wondering if Appian at around US$23.76 is pricing in too much risk or leaving something on the table for patient investors. The stock has been volatile, with a 14.3% gain over the last 7 days, set against a 2.7% decline over 30 days and a deeper 30.2% drop year to date. Recent coverage has focused on Appian as a software platform stock during a period when investors have been reassessing growth-oriented companies and their risk profiles. That backdrop helps explain why the short term bounce...

Assessing NIQ Global Intelligence after recent share price moves NIQ Global Intelligence (NIQ) has caught investor attention after recent share price moves, with the stock closing at US$11.20 and showing mixed returns over the past week, month and past 3 months. See our latest analysis for NIQ Global Intelligence. The recent 6.97% 1 day share price return contrasts with a year to date share price return of negative 29.02%. This suggests short term momentum has picked up while longer term...

If you are wondering whether Swarmer's current share price reflects its real value, the recent moves in the stock give you plenty to think about. After recent trading, Swarmer closed at US$27.90, with returns of a 27.2% decline over 7 days, a 39.4% decline over 30 days and a 10.0% decline year to date. This suggests a sharp reset in market expectations. Recent headlines around Swarmer have focused on its position within the broader capital goods sector and how investors are reassessing...

CVB Financial (NasdaqGS:CVBF) has completed its acquisition of Heritage Commerce Corp, creating a larger combined bank. The company has released pro forma financials for 2025 for the merged entity, giving investors a first look at the combined profile. This transaction marks a meaningful change in CVB Financial’s scale and business mix compared with its prior standalone position. CVB Financial, trading at $20.51, now reflects a business that is materially different from the one behind its...

Investors may be wondering whether RingCentral's current share price reflects its true worth, or if the recent price action has left it mispriced in either direction. The stock last closed at US$45.39, with returns of 12.9% over 7 days, 19.5% over 30 days, 64.5% year to date, 70.5% over 1 year, 58.2% over 3 years, and an 80.9% decline over 5 years. This presents a mixed picture of strong rebounds alongside longer term losses. Recent coverage has focused on RingCentral's position as a...

At Progress Software’s 2026 annual meeting, shareholders approved all proposals, including electing nine directors and ratifying Deloitte & Touche LLP as auditor, while management highlighted fiscal 2025 as the strongest year so far. CEO Yogesh Gupta underscored how AI initiatives, targeted acquisitions, and rapid debt reduction are shaping Progress Software’s total growth strategy and customer focus. We’ll now examine how the CEO’s emphasis on AI-driven growth and disciplined acquisitions...

Kyndryl Holdings recently reported fourth-quarter 2026 results showing largely unchanged revenue of US$3.77 billion but a sharp drop in net income to US$17 million, while also completing a share repurchase of 14,300,000 shares for US$398 million under its November 2024 buyback program. A day later, the Arizona Department of Transportation Motor Vehicle Division announced an expanded collaboration with Kyndryl to further modernize its statewide digital services, highlighting Kyndryl’s growing...

If you are wondering whether PTC at around US$147.65 is priced attractively, this article walks through what the current valuation signals might mean for you. The stock has seen an 8.3% move over the last 7 days and 2.6% over the past month, but is still showing a 13.2% decline year to date and a 10.4% decline over the last year, which may catch the eye of investors weighing potential opportunity against recent sentiment. Recent coverage of PTC has focused on its role as a US software...

Curtiss-Wright recently reported its first-quarter 2026 results, with revenue of US$913.69 million and net income of US$128.19 million, alongside completing a multi-year US$1.38 billion share repurchase program covering 17.52% of its shares. The company also advanced its role in next-generation nuclear technology by moving into prototype manufacturing of key systems for X-energy’s Xe-100 reactor, underlining its exposure to the emerging advanced nuclear market. We’ll now examine how the...

In early May 2026, Lumen Technologies announced plans for its subsidiary Level 3 Financing to issue US$1.00 billion of new senior notes and launch concurrent cash tender offers of up to US$750 million for a wide range of existing Lumen, Level 3, and Qwest notes, while also extending exchange offer deadlines for certain long-dated Qwest bonds. At the same time, Lumen reported first quarter 2026 results showing sales of US$2,899 million and a net loss of US$200 million, highlighting how its...

Recent performance snapshot Flowco Holdings (FLOC) has drawn investor interest after a recent stretch in which the stock showed mixed short term moves, including roughly 1% gain over the past day and a modest decline over the past week. Over the past month the stock return is about 19%, while the past 3 months show a gain of roughly 8%, set against a market value of about US$2.2b and a last close of US$24.56. See our latest analysis for Flowco Holdings. Set against a 16.2% 1 year total...

Nuvation Bio has reported that in the first quarter of 2026 it generated US$83.23 million in revenue and US$5.4 million in net income, while the FDA has accepted a supplemental New Drug Application to update IBTROZI’s label with longer-term data in advanced ROS1-positive non-small cell lung cancer. These developments, alongside IBTROZI’s addition to NCCN guidelines for CNS cancers and strong intracranial response data, reinforce the company’s emerging role in treating ROS1-positive lung...

Wondering if Scholar Rock Holding at around US$46.45 is giving you fair value or a potential opportunity? This article walks through the key numbers in plain language so you can judge for yourself. The stock has seen mixed recent returns, with a 0.3% decline over the last 7 days and a 6.9% decline over the last month, alongside gains of 8.5% year to date, 49.9% over 1 year and a very large 3 year return, plus a 63.3% gain over 5 years. These moves have come as investors weigh ongoing...

T-Mobile US recently reported past first-quarter 2026 results showing revenue of US$23,107 million and net income of US$2,504 million, while also filing an omnibus shelf registration covering common and preferred stock, debt and other securities. The company is intensifying its network-resilience and broadband push through AI-powered emergency connectivity tools, expanded satellite services with Starlink, and new fiber joint ventures that could broaden its high-speed internet footprint to...

Niagen Bioscience (NAGE) is back on investors’ radar after reporting Q1 2026 results that exceeded consensus estimates, alongside the launch of its Niagen Plus telehealth platform and at-home prescription injection kits. See our latest analysis for Niagen Bioscience. Despite the upbeat Q1 report and new Niagen Plus initiatives, the stock’s recent momentum has been weak, with a 30 day share price return of a 6.26% decline and a year to date share price return of a 32.96% decline. The 3 year...

BigBear.ai Holdings (BBAI) just posted its Q1 2026 results, reporting US$34.44 million in sales and a net loss of US$56.76 million. The company also reaffirmed its full year 2026 revenue guidance of US$135 million to US$165 million. See our latest analysis for BigBear.ai Holdings. BigBear.ai’s Q1 update, including the US$53 million classified contract and growing AI platform exposure, comes after a 20.87% 1 month share price return but a 28.60% year to date share price decline. The 3 year...

Investors may be wondering whether Evercore, at around US$331 per share, still offers value or whether most of the easy gains are already behind it. The stock has delivered a 3.1% move over the last week and 7.9% over the past month, while year to date it is at a 5.7% decline against a 54.6% return over the last year, a 225.1% return over three years, and 154.1% over five years. Recent coverage has focused on Evercore's role in major advisory mandates and its position within capital markets...

Wondering if Hercules Capital's share price really reflects what you are getting for your money? This breakdown walks through what the current market price might be missing or already pricing in. Recently, the stock closed at US$16.40, with returns of 2.2% over 7 days, 8.5% over 30 days, 4.0% over 1 year and 67.6% over both 3 and 5 years, while the year to date return sits at a 13.0% decline. These moves sit against a backdrop of ongoing interest in income focused business development...

In early May 2026, Restaurant Brands International reported first-quarter 2026 results with revenue rising to US$2,264 million and net income reaching US$338 million, while also completing a US$59.86 million share repurchase tranche and affirming a quarterly dividend of US$0.65 per share. Beneath the headline beat, investors focused on the contrasting performance across brands, with strong Burger King momentum offset by weaker Popeyes results and higher cost concerns in the Restaurant...

Shopify (SHOP) just posted first quarter results with strong revenue growth, heavy investment in AI tools, and fresh guidance, yet the stock has pulled back sharply, catching investor attention across Wall Street and options markets. See our latest analysis for Shopify. That sharp post earnings pullback sits on top of a much weaker 2026 share price trend, with a year to date share price return of around negative 29%, even as 1 year total shareholder return is about 19% and 3 year total...

Praxis Precision Medicines (NasdaqGS:PRAX) reported that the FDA accepted New Drug Applications for ulixacaltamide and relutrigine. The company is preparing for potential U.S. launches following these NDA acceptances. Praxis also highlighted clinical progress for elsunersen, adding to momentum across its late-stage pipeline. For readers tracking central nervous system drug developers, Praxis sits at an important point in its evolution, with ulixacaltamide and relutrigine moving into formal...

Mach Natural Resources earnings and portfolio shift Mach Natural Resources (MNR) has just reported first quarter 2026 results that paired higher revenue with a net loss, while also redirecting capital toward oil weighted drilling projects and away from some gas focused activity. See our latest analysis for Mach Natural Resources. At a share price of $13.18, Mach Natural Resources has a year to date share price return of 17.16%, while the 1 year total shareholder return sits at 13.32%. This...

Why Mondelez International (MDLZ) Is Back on Investors’ Radar Mondelez International (MDLZ) has attracted fresh attention after recent share moves, with the stock showing mixed short term returns and a modest gain over the past month. This has prompted closer inspection of its fundamentals. See our latest analysis for Mondelez International. At a share price of $61.31, Mondelez’s recent 30-day share price return of 6.61% contrasts with a weaker 1-year total shareholder return of a 5.75%...

If you are wondering whether Gulfport Energy, at a last close of US$178.80, is attractively priced or if the easy gains are behind it, this article breaks down what the current share price might be implying about the stock's value. The stock has seen a 7.1% decline over the last week, a 13.9% decline over the last month, and a 13.3% decline year to date, set against a 94.6% return over the last 3 years and a 5.0% decline over the last year. Recent coverage has focused on Gulfport Energy's...